Polaris Pharmacy Services, a leading provider of long-term care and specialty pharmacy solutions, has been selected as the exclusive U.S. distributor for FluMist® Home, AstraZeneca’s at-home flu vaccine service available for the 2025-2026 flu season.

Through FluMist Home, individuals can order FluMist online to be delivered directly to their home on a date they choose—no doctor’s visit or needle required. The program is the first of its kind to receive FDA approval and has officially launched in the U.S.

“We are proud to partner with AstraZeneca to bring this innovative, direct-to-consumer solution to families across the country,” said David Rombro, RPh, Chief Executive Officer of Polaris Pharmacy Services. “As the exclusive pharmacy distributor for FluMist Home, Polaris is leading the charge in redefining how preventive care is delivered in the U.S.”

Andrew Leone, Executive Director Marketing and Sales, US Vaccines & Immune Therapies AstraZeneca said, “Our partnership with Polaris Pharmacy Services reflects a shared vision to bring cutting-edge innovation and convenience directly to families and communities across the U.S. Together, we are empowering individuals and their families to help bring flu protection home.”

Launched in collaboration with its HUB services partner, Asembia, and ASPN Pharmacies—which provides the technology platform and backend services—Polaris has begun dispensing and shipping vaccines from five state-of-the-art pharmacy locations. To support the specialized temperature-control requirements of the product, Polaris has invested in advanced cold chain capabilities at each location, demonstrating the company’s commitment to operational excellence and innovation in pharmaceutical logistics.

To learn more about FluMist Home and to confirm your eligibility, visit https://www.flumist.com/.

About Polaris Pharmacy Services

Experience the future of pharmacy care with Polaris Pharmacy Services. As leaders in specialty, long-term and post-acute care, corrections, and PACE pharmacy solutions, Polaris is elevating pharmacy standards by combining clinical expertise with advanced technology to improve outcomes, optimize costs, and enhance the patient experience. Founded in 2015, Polaris is independently owned with more than 20 pharmacies nationwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250821742830/en/